FDA Increases Oversight of Diagnostic Tests
The Food and Drug Administration has issued new rules aimed at bolstering the agency’s oversight and regulation of the diagnostic testing field. Specifically, the FDA is taking aim at Laboratory-Developed Tests (LDTs), which are defined as in vitro medical tests designed, manufactured, and processed by a single clinical laboratory. Historically, LDTs were unique, highly targeted […]